Home » Topics » Regulatory

Regulatory
RSS

Clarinex approved by FDA for perennial allergic rhinitis and chronic idiopathic urticaria

Feb. 14, 2002

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...